Fusion’s future in the US could come down to dollars and cents
Money for fusion energy. Credit: Bumper DeJesus
Fusion energy is often hailed as a limitless source of clean energy, but new research from…
Browsing Tag
fusions
Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions: Phase I/II trial…
The highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses in patients with RET fusion-positive cancers regardless of tumor type, according to results from the international Phase I/II ARROW…